Skip to main content
Top
Published in: Medical Microbiology and Immunology 2/2023

Open Access 30-03-2023 | SARS-CoV-2 | Editorial

Editorial on special issue on “Immunobiology of Viral Infections”

Authors: Hanna-Mari Baldauf, Asisa Volz

Published in: Medical Microbiology and Immunology | Issue 2/2023

Login to get access

Excerpt

A host cell has many ways how to interfere with invading viral pathogens. The fastest reaction is provided by the innate immunity, but also the adaptive immunity plays an important role to control viral replication. In the first case, viruses can be recognized by pattern recognition receptors (PRRs) or cytosolic sensors, which then trigger production and release of interferons (IFNs) and upregulation of IFN-stimulated genes, which further block viral replication by distinct mechanisms. For efficient replication, viruses, however, have evolved counteracting mechanisms. Thus, those virus-host interactions culminate in an arms-race with the host, which also leave genetic imprints on both, the viral genes and the antiviral host genes. From the viral point of view, it is of course necessary to overcome limitations imposed by the host. The aim of this special issue is to provide the readers the latest findings concerning the immunobiology of viral infections. …
Literature
Metadata
Title
Editorial on special issue on “Immunobiology of Viral Infections”
Authors
Hanna-Mari Baldauf
Asisa Volz
Publication date
30-03-2023
Publisher
Springer Berlin Heidelberg
Keyword
SARS-CoV-2
Published in
Medical Microbiology and Immunology / Issue 2/2023
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-023-00761-0

Other articles of this Issue 2/2023

Medical Microbiology and Immunology 2/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine